Celon Pharma S.A. (WSE:CLN)
15.50
+0.10 (0.65%)
Nov 18, 2026, 4:59 PM CET
| Market Cap | 834.78M -27.6% |
| Revenue (ttm) | 257.64M +24.9% |
| Net Income | 106.81M |
| EPS | 2.04 |
| Shares Out | 53.86M |
| PE Ratio | 7.60 |
| Forward PE | 22.40 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 34,868 |
| Open | 15.34 |
| Previous Close | 15.40 |
| Day's Range | 15.30 - 15.86 |
| 52-Week Range | 15.20 - 23.50 |
| Beta | 0.60 |
| Analysts | Sell |
| Price Target | 20.38 (+31.48%) |
| Earnings Date | Nov 18, 2026 |